Authentication and Adulteration Detection of Herbal Raw Materials Using DNA Barcoding and FTIR Fingerprinting
Published in IJPHDT, Vol-2, Issue-11, Nov-2025 (Vol. 2, Issue 11, 2025)
Keywords
Abstract
Authors (5)
B Sabana Sabana
Department of Biochemistry and Bioinformatics Dr MGR Janaki college for women, Adyar, Chennai 28
View all publications →T Uma Venkatalakshmi Venkatalakshmi
Department of Biochemistry and Bioinformatics, Dr MGR Janaki college for women, Adyar, Chennai 28
View all publications →Anjum. A Anjum
Justice Basheer Ahmed Sayeed College for Women (Autonomous), Chennai
View all publications →R.Ramya Ramya
Department of Biochemistry, J.B.A.S. College for Women Teynampet, Chennai -18
View all publications →Bhuvaneswari.G G
Department of Biochemistry, Annai Veilankanni’s College for Women
View all publications →Download Article
Best for printing and citation
Article Information
- Article ID:
- IJPHD-00000201
- Paper ID:
- IJPHD-01-000201
How to Cite
Sabana, B. & T Uma Venkatalakshmi Venkatalakshmi & A, A. & Ramya & G (2025). Authentication and Adulteration Detection of Herbal Raw Materials Using DNA Barcoding and FTIR Fingerprinting. International Journal of Pharmacognosy and Herbal Drug Technology, 2(11), xx-xx. https://ijphdt.scholarjms.com/articles/86
Article Actions
Article Impact
More from this Issue
Anti-Inflammatory Herbs in Rheumatoid Arthritis: Mechanistic In Vitro Studies and Translational Potential
Key anti-inflammatory herbal compounds—curcumin, curcumin analogues, resveratrol, boswellic acids derived from Boswellia serrata, and Tripterygium wilfordii extracts—are reviewed in this study, together with mechanistic in vitro data and translational implications, for the management of rheumatoid arthritis (RA). This research provides a summary of their molecular processes, which include cytokine suppression, NF-κB inhibition, antioxidant action, and immunological modulation, based solely on recent systematic reviews, meta-analyses, preclinical evaluations, and randomized trials. Emerging clinical translation in autoimmune illnesses and osteoarthritis is supported by good molecular evidence for these herbs, especially curcumin, resveratrol, and boswellic acids. Bioavailability, consistent dosage, and long-term safety are still areas where research is lacking in RA. Optimized formulations, high-quality RA-specific clinical studies, and mechanistic validation through in vitro disease models should be the priorities of future research.
Antiviral Potential of Medicinal Plants Against Respiratory Viruses: In Vitro Screening and In Silico Prioritization
Medicinal plants represent a promising source of antiviral agents against respiratory viruses, supported by evidence from in vitro, in vivo, and in silico studies. Key bioactive compounds, including silymarin from Silybum marianum, germacrone from Geranium macrorrhizum, and licochalcone A from Glycyrrhiza glabra, have demonstrated the ability to reduce viral replication, inhibit viral enzymes such as neuraminidase, interfere with viral entry, and modulate host immune signaling pathways, enhancing viral clearance. Traditional multi-herb formulations, including Japanese medicines like Shahakusan and Hochuekkito, also show measurable antiviral activity, reflecting historical therapeutic applications. Despite these promising findings, challenges remain in standardizing extracts, evaluating pharmacokinetics and safety, and bridging in vitro potency to in vivo efficacy. Integrating in silico prioritization with systematic preclinical studies is essential to guide the selection of candidate phytochemicals for clinical translation. Overall, these findings highlight the potential of plant-derived antivirals as safe, effective, and complementary therapeutics for both human and veterinary respiratory viral infections.
Green-Synthesized Metallic Nanoparticles Using Herbal Extracts: Characterization and Antibacterial Efficacy
An uptick in research into green synthesis methods, especially those that make use of plant extracts, can be attributed to the rising need for sustainable and environmentally friendly nanomaterials. Antibacterial activity against Staphylococcus aureus and Escherichia coli was assessed in this study, which also looked at the green manufacture of metallic nanoparticles using Ocimum sanctum herbal extract. Analyses using UV-Visible spectroscopy, FTIR, SEM, and XRD verified the successful production of nanoparticles. S. aureus was more susceptible than E. coli in antibacterial experiments, which showed a noticeable rise in inhibitory zones that was dose dependent. The produced nanoparticles' powerful antibacterial effectiveness was confirmed by statistical analysis employing one-way ANOVA, which showed significant differences (p